NORTH AMERICA VETERINARY VACCINES MARKET 2022-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	102 Pages	Triton Market Research	May, 2022	TRTN17170494

Best Price Guarantee
Price	from $1,500
Length	102 Pages
Publisher	Triton Market Research
Published Date	May, 2022
SKU	TRTN17170494

North America Veterinary Vaccines Market 2022-2028

MARKET OUTLOOK

Triton Market Research’s study shows the probable growth of the veterinary vaccines market in North America at a CAGR of 6.91% over the years 2022 to 2028. The United States and Canada highlight the overall progress within the region.

The North American veterinary vaccines market showed a robust growth given the rise in animal diseases, increased R&D, and other government incentives.

The United States is among the leading countries in the veterinary vaccines market. The demand for vaccines in the country is expanding due to a mass livestock population. In this regard, major leading players like Merck Animal Health and Zoetis Inc provide robust solutions to vaccinate livestock. Moreover, the country has the largest population of companion animals, making it one of the biggest markets for vaccine producers. These factors boost the growth process of the veterinary vaccines market.

Likewise, Canada’s veterinary vaccines market is likely to grow due to the rising companion animal population. Additionally, there is an increasing risk of animal disease due to abundant livestock. As such, the government of Canada is largely supporting the vaccine market players through investments in more than 5,000 projects, which has improved the veterinary services. Therefore, the growing agricultural sector is expected to provide ample opportunities for the veterinary vaccines market in Canada.

COMPETITIVE OUTLOOK

The prominent companies contributing to the growth of the veterinary vaccines market include Merck Animal Health, Phibro Animal Health, Vaxxinova GmbH, Hester Biosciences Ltd, Elanco Animal Health Inc, and Ceva Sante Animale.

1. North America Veterinary Vaccines Market – Summary
2. Industry Outlook: 2.1. Impact Of Covid-19 On The Veterinary Vaccines Market; 2.2. Key Insights; 2.2.1. Increasing Innovation By Market Participants; 2.2.2. Advancements In Vaccine And Diagnostic Technology; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Market Attractiveness Index; 2.5. Value Chain Analysis; 2.6. Key Buying Criteria; 2.7. Regulatory Framework; 2.8. Vendor Scorecard; 2.9. Key Market Strategies; 2.9.1. Mergers & Acquisitions; 2.9.2. Contracts & Agreements; 2.9.3. Product Launches; 2.9.4. Expansions & Divestitures; 2.10. Market Drivers; 2.10.1. High Vaccine Demand Due To Increasing Animal Population And Diseases; 2.10.2. Government-organized Vaccination Drives; 2.10.3. Advanced Vaccine Research And Development; 2.11. Market Challenges; 2.11.1. Lack Of Awareness And Scarcity Of Skilled Veterinarians; 2.11.2. Stringent Rules And Regulations Pertaining To Vaccine Use; 2.12. Market Opportunities; 2.12.1. Growing Use Of Vaccines In The American Market; 2.12.2. Rising Demand For Companion Animals
3. North America Veterinary Vaccines Market Outlook – By Animal Type: 3.1. Livestock Animals; 3.1.1. Cattle; 3.1.2. Pigs; 3.1.3. Poultry; 3.1.4. Sheep; 3.1.5. Other Livestock Animals; 3.2. Companion Animals; 3.2.1. Canine; 3.2.2. Feline; 3.2.3. Equine; 3.3. Aquaculture
4. North America Veterinary Vaccines Market Outlook – By Disease Type: 4.1. Canine Disease; 4.2. Porcine Disease; 4.3. Bovine Disease; 4.4. Poultry Disease; 4.5. Aquaculture Disease; 4.6. Other Disease Types
5. North America Veterinary Vaccines Market Outlook – By Product Type: 5.1. Attenuated Vaccines; 5.2. Inactivated Vaccines; 5.3. Toxoid Vaccines; 5.4. Conjugate Vaccines; 5.5. Dna Vaccines; 5.6. Recombinant Vaccines; 5.7. Subunit Vaccines
6. North America Veterinary Vaccines Market – Country Outlook: 6.1. United States; 6.2. Canada
7. Competitive Landscape: 7.1. Boehringer Ingelheim International Gmbh; 7.2. Brilliant Bio Pharma; 7.3. Ceva Sante Animale; 7.4. Elanco Animal Health Inc; 7.5. Hester Biosciences Ltd; 7.6. Hipra; 7.7. Indian Immunologicals Limited; 7.8. Merck Animal Health; 7.9. Phibro Animal Health; 7.10. Vaxxinova Gmbh; 7.11. Virbac Sa; 7.12. Zoetis Inc
8. Research Methodology & Scope: 8.1. Research Scope & Deliverables; 8.2. Sources Of Data; 8.3. Research Methodology
Table List: Table 1: North America Veterinary Vaccines Market, By Country, 2022-2028 (In $ Million); Table 2: Regulatory Framework; Table 3: Vendor Scorecard; Table 4: North America Veterinary Vaccines Market, By Animal Type, 2022-2028 (In $ Million); Table 5: North America Veterinary Vaccines Market, By Livestock Animals, 2022-2028 (In $ Million); Table 6: North America Veterinary Vaccines Market, By Companion Animals, 2022-2028 (In $ Million); Table 7: North America Veterinary Vaccines Market, By Disease Type, 2022-2028 (In $ Million); Table 8: North America Veterinary Vaccines Market, By Product Type, 2022-2028 (In $ Million); Table 9: North America Veterinary Vaccines Market, By Country Outlook, 2022-2028 (In $ Million)
Figure List: Figure 1: Market Attractiveness Index; Figure 2: Value Chain Analysis; Figure 3: Key Buying Criteria; Figure 4: North America Veterinary Vaccines Market, By Animal Type, 2021 & 2028 (In %); Figure 5: North America Veterinary Vaccines Market, By Livestock Animals, 2022-2028 (In $ Million); Figure 6: North America Veterinary Vaccines Market, By Livestock Animals, 2021 & 2028 (In %); Figure 7: North America Veterinary Vaccines Market, By Cattle, 2022-2028 (In $ Million); Figure 8: North America Veterinary Vaccines Market, By Pigs, 2022-2028 (In $ Million); Figure 9: North America Veterinary Vaccines Market, By Poultry, 2022-2028 (In $ Million); Figure 10: North America Veterinary Vaccines Market, By Sheep, 2022-2028 (In $ Million); Figure 11: North America Veterinary Vaccines Market, By Other Livestock Animals, 2022-2028 (In $ Million); Figure 12: North America Veterinary Vaccines Market, By Companion Animals, 2022-2028 (In $ Million); Figure 13: North America Veterinary Vaccines Market, By Companion Animals, 2021 & 2028 (In %); Figure 14: North America Veterinary Vaccines Market, By Canine, 2022-2028 (In $ Million); Figure 15: North America Veterinary Vaccines Market, By Feline, 2022-2028 (In $ Million); Figure 16: North America Veterinary Vaccines Market, By Equine, 2022-2028 (In $ Million); Figure 17: North America Veterinary Vaccines Market, By Aquaculture, 2022-2028 (In $ Million); Figure 18: North America Veterinary Vaccines Market, By Disease Type, 2021 & 2028 (In %); Figure 19: North America Veterinary Vaccines Market, By Canine Disease, 2022-2028 (In $ Million); Figure 20: North America Veterinary Vaccines Market, By Porcine Disease, 2022-2028 (In $ Million); Figure 21: North America Veterinary Vaccines Market, By Bovine Disease, 2022-2028 (In $ Million); Figure 22: North America Veterinary Vaccines Market, By Poultry Disease, 2022-2028 (In $ Million); Figure 23: North America Veterinary Vaccines Market, By Aquaculture Disease, 2022-2028 (In $ Million); Figure 24: North America Veterinary Vaccines Market, By Other Disease Type, 2022-2028 (In $ Million); Figure 25: North America Veterinary Vaccines Market, By Product Type, 2021 & 2028 (In %); Figure 26: North America Veterinary Vaccines Market, By Attenuated Vaccines, 2022-2028 (In $ Million); Figure 27: North America Veterinary Vaccines Market, By Inactivated Vaccines, 2022-2028 (In $ Million); Figure 28: North America Veterinary Vaccines Market, By Toxoid Vaccines, 2022-2028 (In $ Million); Figure 29: North America Veterinary Vaccines Market, By Conjugate Vaccines, 2022-2028 (In $ Million); Figure 30: North America Veterinary Vaccines Market, By Dna Vaccines, 2022-2028 (In $ Million); Figure 31: North America Veterinary Vaccines Market, By Recombinant Vaccines, 2022-2028 (In $ Million); Figure 32: North America Veterinary Vaccines Market, By Subunit Vaccines, 2022-2028 (In $ Million); Figure 33: North America Veterinary Vaccines Market, Country Outlook, 2021 & 2028 (In %); Figure 34: United States Veterinary Vaccines Market 2022-2028 (In $ Million); Figure 35: Canada Veterinary Vaccines Market 2022-2028 (In $ Million)